SIDARSO

This brand name is authorized in Estonia, Lithuania, Poland, Romania

Active ingredients

The drug SIDARSO contains one active pharmaceutical ingredient (API):

1 Silodosin UNII CUZ39LUY82 - SILODOSIN

Silodosin is highly selective for α1A-adrenoreceptors that are primarily located in the human prostate, bladder base, bladder neck, prostatic capsule and prostatic urethra. Blockade of these α1A-adrenoreceptors causes smooth muscle in these tissues to relax, thus decreasing bladder outlet resistance, without affecting detrusor smooth muscle contractility. Read about Silodosin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04CA04	Silodosin	G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CA Alpha-adrenoreceptor antagonists
Discover more medicines within G04CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1770735, 1770746, 1770757, 1770768, 1770779, 1770780, 1770791, 1770803, 1770814, 1770825, 1770836, 1770847
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1087986, 1087987, 1087988, 1087989, 1087990, 1087991, 1087992, 1087993, 1087994, 1087995, 1087996, 1087997, 1087998, 1087999, 1088000, 1088001, 1088002, 1088003, 1088004, 1088005, 1088006, 1088007, 1088008, 1088009
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100405426, 100405432
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66131001, W66131002, W66131003, W66131004, W66131005, W66131006, W66131007, W66131008, W66131009, W66131010, W66131011, W66131012, W66132001, W66132002, W66132003, W66132004, W66132005, W66132006, W66132007, W66132008, W66132009, W66132010, W66132011, W66132012